# AKYNZEO

NDC: 69639-101
Generic name: Netupitant and Palonosetron
Labeler / Manufacturer: Helsinn Therapeutics (U.S.), Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20141013

FDA application: NDA205718

## Active ingredients

- NETUPITANT: 300 mg/1
- PALONOSETRON: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69639-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69639-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e47618e-af46-4d82-94e8-1507c042252d